Hepatitis C: the path towards effective universal therapy
Lancet
.
2016 Sep 10;388(10049):1051-1052.
doi: 10.1016/S0140-6736(16)31540-9.
Authors
Lionel Piroth
1
,
Christian Rabaud
2
,
David Rey
3
,
Jean-Luc Schmit
4
,
Catherine Chirouze
5
,
Geneviève Beck-Wirth
6
,
Olivier Robineau
7
,
Firouze Bani-Sadr
8
;
ICONE Study Group
Affiliations
1
Infectious Diseases Department, CHU Dijon, 21079 Dijon Cedex, France. Electronic address:
[email protected]
.
2
Infectious Diseases Department, CHU Nancy, Nancy, France.
3
HIV Infection Care Centre, CHU Strasbourg, Strasbourg France.
4
Infectious Diseases Department, CHU Amiens, Amiens France.
5
Infectious Diseases Department, CHU Besançon, Besançon, France.
6
Internal Medicine Department, Groupe Hospitalier Régional, Mulhouse, France.
7
Infectious Diseases Department, Centre hospitalier Gustave Dron, Tourcoing, France.
8
Infectious Diseases Unit, CHU Reims, Reims, France.
PMID:
27628513
DOI:
10.1016/S0140-6736(16)31540-9
No abstract available
Publication types
Letter
Comment
MeSH terms
Hepacivirus*
Hepatitis B
Hepatitis C*
Humans